Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes.

Forbes JM, Söderlund J, Yap FY, Knip M, Andrikopoulos S, Ilonen J, Simell O, Veijola R, Sourris KC, Coughlan MT, Forsblom C, Slattery R, Grey ST, Wessman M, Yamamoto H, Bierhaus A, Cooper ME, Groop PH.

Diabetologia. 2011 May;54(5):1032-42. doi: 10.1007/s00125-011-2058-z. Epub 2011 Feb 6. Erratum in: Diabetologia. 2011 Jun;54(6):1586-7.

PMID:
21298413
2.

The functional -374T/A polymorphism of the receptor for advanced glycation end products may modulate Crohn's disease.

Däbritz J, Friedrichs F, Weinhage T, Hampe J, Kucharzik T, Lügering A, Broeckel U, Schreiber S, Spieker T, Stoll M, Foell D.

Am J Physiol Gastrointest Liver Physiol. 2011 May;300(5):G823-32. doi: 10.1152/ajpgi.00115.2010. Epub 2011 Feb 10.

3.
4.

Polymorphisms of the receptor of advanced glycation endproducts (RAGE) and the development of nephropathy in type 1 diabetic patients.

Prevost G, Fajardy I, Besmond C, Balkau B, Tichet J, Fontaine P, Danze PM, Marre M; Genediab and D.E.S.I.R studies..

Diabetes Metab. 2005 Feb;31(1):35-9.

PMID:
15803111
5.

The HLA 8.1 ancestral haplotype is strongly linked to the C allele of -429T>C promoter polymorphism of receptor of the advanced glycation endproduct (RAGE) gene. Haplotype-independent association of the -429C allele with high hemoglobinA1C levels in diabetic patients.

Laki J, Kiszel P, Vatay A, Blaskó B, Kovács M, Körner A, Madácsy L, Blatniczky L, Almássy Z, Szalai C, Rajczy K, Pozsonyi E, Karádi I, Fazakas A, Hosszúfalusi N, Pánczél P, Arason GJ, Wu YL, Zhou B, Yang Y, Yu CY, Füst G.

Mol Immunol. 2007 Jan;44(4):648-55. Epub 2006 Feb 28.

PMID:
16504296
6.

Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice.

Yamamoto Y, Kato I, Doi T, Yonekura H, Ohashi S, Takeuchi M, Watanabe T, Yamagishi S, Sakurai S, Takasawa S, Okamoto H, Yamamoto H.

J Clin Invest. 2001 Jul;108(2):261-8.

7.

Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.

Shoji T, Koyama H, Morioka T, Tanaka S, Kizu A, Motoyama K, Mori K, Fukumoto S, Shioi A, Shimogaito N, Takeuchi M, Yamamoto Y, Yonekura H, Yamamoto H, Nishizawa Y.

Diabetes. 2006 Aug;55(8):2245-55.

8.

Advanced glycation end products as environmental risk factors for the development of type 1 diabetes.

Yap FY, Kantharidis P, Coughlan MT, Slattery R, Forbes JM.

Curr Drug Targets. 2012 Apr;13(4):526-40. Review.

PMID:
22250649
9.

Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients.

Cunha C, Giovannini G, Pierini A, Bell AS, Sorci G, Riuzzi F, Donato R, Rodrigues F, Velardi A, Aversa F, Romani L, Carvalho A.

PLoS One. 2011;6(11):e27962. doi: 10.1371/journal.pone.0027962. Epub 2011 Nov 17.

10.

A role for advanced glycation end products in diminished bone healing in type 1 diabetes.

Santana RB, Xu L, Chase HB, Amar S, Graves DT, Trackman PC.

Diabetes. 2003 Jun;52(6):1502-10.

11.

The functional -374 T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients.

Pettersson-Fernholm K, Forsblom C, Hudson BI, Perola M, Grant PJ, Groop PH; Finn-Diane Study Group..

Diabetes. 2003 Mar;52(3):891-4.

12.

The -429 T>C polymorphism of the receptor for advanced glycation end products (RAGE) is associated with type 1 diabetes in a Brazilian population.

Picheth G, Heidemann M, Pedrosa FO, Chautard-Freire-Maia EA, Costantini CO, da Rocha Martinez TL, de Souza EM.

Clin Chim Acta. 2007 Aug;383(1-2):163-4. Epub 2007 Apr 13. No abstract available.

PMID:
17512509
13.

Genetic predisposition to advanced glycation end products toxicity is related to prognosis of chronic hemodialysis patients.

Kalousová M, Jáchymová M, Germanová A, Kubena AA, Tesar V, Zima T.

Kidney Blood Press Res. 2010;33(1):30-6. doi: 10.1159/000285845. Epub 2010 Feb 23.

14.

Relationship between the -374T/A RAGE gene polymorphism and angiographic coronary artery disease.

Falcone C, Campo I, Emanuele E, Buzzi MP, Zorzetto M, Sbarsi I, Cuccia M.

Int J Mol Med. 2004 Dec;14(6):1061-4.

PMID:
15547674
15.
16.

The -374A allele of the receptor for advanced glycation end products gene is associated with a decreased risk of ischemic heart disease in African-Brazilians with type 2 diabetes.

dos Santos KG, Canani LH, Gross JL, Tschiedel B, Pires Souto KE, Roisenberg I.

Mol Genet Metab. 2005 Jun;85(2):149-56. Epub 2005 Mar 24.

PMID:
15896660
17.

The Gly82Ser polymorphism of the receptor of advanced glycation end product (RAGE) gene is not associated with type 1 or type 2 diabetes in a Brazilian population.

Naka CL, Picheth G, Alcântera VM, Réa RR, Chautard-Freire-Maia EA, Pedrosa Fde O, Martinez TL, Souza EM.

Diabetes Care. 2006 Mar;29(3):712-3. No abstract available.

PMID:
16505535
18.
20.

Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis.

Kim W, Hudson BI, Moser B, Guo J, Rong LL, Lu Y, Qu W, Lalla E, Lerner S, Chen Y, Yan SS, D'Agati V, Naka Y, Ramasamy R, Herold K, Yan SF, Schmidt AM.

Ann N Y Acad Sci. 2005 Jun;1043:553-61. Review.

PMID:
16037278

Supplemental Content

Support Center